Human Aminopeptidase PILS/ARTS1 Antibody
R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Species Reactivity: | Human |
Immunogen: |
Mouse myeloma cell line NS0-derived recombinant human Aminopeptidase PILS/ARTS1 Ala37-Met941 Accession # EAW96077 |
Applications: | Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunoprecipitation, Simple Western, Western Blot |
Label: | Unconjugated |
Source: | Polyclonal Goat IgG |
Specificity: |
Detects human Aminopeptidase PILS/ARTS1 in direct ELISAs and Western blots. In direct ELISAs, approximately 45% cross‑reactivity with recombinant mouse ARTS1 is observed. |
Customers also Viewed
Customers also Purchased
Citations for Human Aminopeptidase PILS/ARTS1 Antibody (4)
Citations are publications that use Bio-Techne products. Selected citations for Human Aminopeptidase PILS/ARTS1 Antibody include:
-
Species: Human
Sample Types: Cell Lysates
Applications: Western BlotI Temponeras et al. (2022), ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides International Journal of Molecular Sciences, 23(3).
PMID: 35163832 -
Species: Human
Sample Types: Cell Lysates
Applications: Western BlotP Jiang et al. (2021), Interaction between ERAP Alleles and HLA Class I Types Support a Role of Antigen Presentation in Hodgkin Lymphoma Development Cancers, 13(3).
PMID: 33499248 -
Species: Human
Sample Types: Cell Lysates
Applications: Western BlotA Papakyriak et al. (2018), The partial dissociation of MHC class I bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1 J. Biol. Chem., 0(0).
PMID: 29599287 -
Species: Human
Sample Types: Whole Cells
Applications: ICCSR Harrison et al. (2018), Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across ThreeTNFRSF1AMutations Results in Hyperresponsiveness to Lipopolysaccharide Front Immunol, 9(0):173.
PMID: 29467762
There are no citations that match your criteria.